# Cybin D/B/A Helus Pharma (HELP): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Cybin D/B/A Helus Pharma (HELP) is 38/100, ranked against 25,000+ stocks in 38 markets (Quality 33, Value 29, Momentum 68, each scored against its sector).

- MoatMap Score: 38/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 33, Value 29, Momentum 68: each a 0-100 percentile within Healthcare.
- Position: #16,395 overall, #1,429 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 8.86 USD on 12 Nov 2026.
- Insider filings, last 180 days: directors bought USD 39K.

Source: https://moatmap.ai/stock/HELP
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker